Humana, Providence Leverage FHIR to Streamline Data Exchange
Payer and provider organization anticipate their framework will be easily replicable, serving as a scalable model for the industry
Payer and provider organization anticipate their framework will be easily replicable, serving as a scalable model for the industry
This data note presents findings from the KFF Women’s Health Survey on women’s health status, access to health care services, and use of preventive health services.
Artificial intelligence (AI) and advanced analytics can assist hospitals as they endure the uncertainty caused by tariffs. The post How Hospitals Can Blunt the Effects of Tariffs appeared first on MedCity News.
Health and Human Services Secretary Robert F. Kennedy Jr. is caught between his Make America Healthy Again supporters who want him to do more to advance their priorities, including curtailing vaccines, and a White House trying to combat President Donald Trump’s unpopularity. Protesters’ chants could be heard from inside the Cleveland City Club, where Kennedy…
Durante una cena bajo palmeras en la terraza de Mar-a-Lago en diciembre, el presidente electo Donald Trump tranquilizó a los directores ejecutivos de las farmacéuticas Eli Lilly y Pfizer diciéndoles que el activista antivacunas Robert F. Kennedy Jr. no sería una elección radical para dirigir el Departamento de Salud y Servicios Humanos (HHS). “Creo que…
A Fortina Hernández la llaman “la que lo sabe todo”. Durante más de dos décadas, esta trabajadora de salud comunitaria ha ayudado a cientos de familias del sureste de Los Ángeles a inscribirse en programas de ayuda alimentaria, ha informado sobre seguros médicos asequibles y ha ayudado con medicamentos para sus afecciones crónicas. Su frase…
VA’s Electronic Health Record Modernization Office expects to go live at 13 sites in 2026
Pharmaceutical tariffs are coming, part of President Trump’s stated goal of bringing drug manufacturing back to the U.S. Untangling the sprawling, global supply chain will be complicated and expensive, and could inadvertently compete with other administration goals regarding drug pricing and availability. The post The Myth of All-American Drugs and What Trump’s Tariffs Miss About…
The keys are establishing a culture that applauds ideas and learns from “failures” rather than seeking to place blame, recognizing that the best ideas can come from any source, and benefiting from cross-functional discussion and challenge. The post Navigating the Path to Success in Medical Devices: Strategy, Reimbursement, and Competition appeared first on MedCity News.
Soleno Therapeutics’ Vykat XR is now FDA approved for treating hyperphagia, or excessive hunger, in patients with Prader-Willi syndrome. The once-daily pill is the first approved therapy for this rare disease, a leading cause of childhood obesity. The post Rare Metabolic Disease That Leads to Childhood Obesity Gets Its First FDA-Approved Drug appeared first on…